Researchers centered at Nagoya University develop a nanowire device able to detect microscopic levels of urinary markers potentially implicated in cancer
Cells communicate with each other through a number of different mechanisms. Some of these mechanisms are well-known: in animals, for example, predatory threats can drive the release of norepinephrine, a hormone that travels through the bloodstream and triggers heart and muscle cells to initiate a “fight-or-flight” response.
A far less familiar mode of cellular transport is the extracellular vesicle (EV). EVs can be thought of as small “chunks” of a cell that are able to pinch off and circulate throughout the body to deliver messenger cargo to other cells. These messengers have become increasingly recognized as crucial mediators of cell-to-cell communication.
In a new study reported in Science Advances, researchers centered at Nagoya University have developed a novel medical device that can efficiently capture these EVs, and potentially use them to screen for cancer.
Video 1: MicroRNA extraction using nanowires
After introducing a urine sample onto the device, extracellular vesicles are captured by a nanowire substrate via electrostatic forces. MicroRNAs can then be directly extracted from the substrate. Takao Yasui
“EVs are potentially useful as clinical markers. The composition of the molecules contained in an EV may provide a diagnostic signature for certain diseases,” lead author Takao Yasui explains. “The ongoing challenge for physicians in any field is to find a non-invasive diagnostic tool that allows them to monitor their patients on a regular basis–for example, a simple urine test.”
Among the many molecules EVs have been found to harbor are microRNAs, which are short pieces of ribonucleic acid that play diverse roles in normal cellular biology. Critically, the presence of certain microRNAs in urine might serve as a red flag for serious conditions such as bladder and prostate cancer. While this important cargo could therefore theoretically aid physicians in cancer diagnoses, there are still many technological hurdles that need to be overcome. One such hurdle: finding a feasible method to capture EVs in sufficient quantities to analyze them in a routine clinical setting.
“The content of EVs in urine is extremely low, at less than 0.01% of the total fluid volume. This is a major barrier to their diagnostic utility,” Yasui notes. Our solution was to embed zinc oxide nanowires into a specialized polymer to create a material that we believed would be highly efficient at capturing these vesicles. Our findings suggest that the device is indeed quite efficient. We obtained a collection rate of over 99%, surpassing ultracentrifugation as well as other methods that are currently being used in the field.”
To test the practicality of their device, the research team compared the microRNAs of EVs isolated from healthy patients with those isolated from patients who were already diagnosed with bladder, prostate, and other forms of cancer. Notably, their technique required only 1 milliliter of urine–far more than the typical “deposit” provided during a routine checkup–and found a substantially greater number and different types of microRNAs compared with the standard ultracentrifugation approach.
Figure 2: Identification of distinct microRNA patterns in healthy donors and cancer patients
Nanowire extraction allowed many microRNAs to be compared at once using urine samples collected from patients. Expression of each microRNA is shown as low/downregulated (blue), intermediate (black), or high/upregulated (yellow). The analysis reveals unique patterns of expression for groups of microRNAs when comparing healthy donors (?) with cancer patients (+). via Takao Yasui
“Finding a specific, reproducible marker to help confirm a cancer diagnosis is difficult. This is especially true for microRNAs, which are a relatively new class of markers in the field,” co-author Yoshinobu Baba explains. “Sometimes finding just one reliable microRNA is considered a success. Using this approach, we were surprised to find that not just one, but whole combinations of microRNAs might be associated with different types of cancers. The findings are preliminary, of course, but we hope our device can help to lay the groundwork for easier ways to diagnose life-threatening diseases as early as possible.”
The Latest on: Detecting cancer
- Novel radiotracer is an effective option for staging of prostate canceron May 11, 2020 at 1:30 pm
The novel radiopharmaceutical 18F-PSMA-1007 is both effective and readily available for detecting malignant prostate cancer lesions, according to research published in the April issue of The Journal ...
- Singlera Genomics Meets with FDA for Rapid Colon Cancer Assay and Has a Clear Path Forwardon May 11, 2020 at 11:08 am
Submission Meeting with the US FDA Center for Devices and Radiological Health, Office of In Vitro Diagnostics on April 21, 2020, after an initial Pre-Submission Meeting in the fall of 2019. The FDA ...
- Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsieson May 11, 2020 at 9:31 am
Prostate cancer (PrCa) is the second most common cancer among men in the United States. The gold standard for detecting PrCa is the examination of prostate needle core biopsies. Diagnosis can be ...
- Reducing Risk Of Fatal Breast Cancer, Study Confirms Strategyon May 11, 2020 at 5:12 am
Researchers analyzed more than a half million women in Sweden and found early mammogram screening significantly reduces the rates of advanced and fatal breast cancer. Their findings are published ...
- Protein-altering germline mutations implicate novel genes related to lung cancer developmenton May 11, 2020 at 2:20 am
In lung cancer, relatively few germline mutations are known to impact risk. Here the authors looked at rare variants in 39,146 individuals and find novel germline mutations associated with risk, as ...
- Early mammography screening lowers risk of developing fatal breast canceron May 11, 2020 at 12:32 am
An analysis of more than half a million women in Sweden reveals that mammography screening reduces the rates of advanced and fatal breast cancers. The findings are published early online in Cancer.
- The challenge of early detection in canceron May 7, 2020 at 1:03 pm
An early detection test could be applied in symptomatic patients to reduce the time between presentation and diagnosis. It could also be applied as a “screening” test in apparently healthy individuals ...
- Burning Rock initiates the first prospective, multi-center pan-cancer early detection study in Chinaon May 7, 2020 at 12:39 am
Burning Rock today announces the initiation of its 14,000 patient PREDICT (Pan-CanceR Early DetectIon ProjeCT) study to further develop and validate its pan-cancer early detection technology. PREDICT ...
- Australian universities tout cancer detection devices and future telco innovationon May 6, 2020 at 9:34 pm
The Australian National University has developed tiny devices aimed at helping identify cancer, meanwhile, the University of Sydney is hoping to use light and sound for future telecommunications ...
- HEALTH: Blood test helped detect cancer before symptoms, study findson May 4, 2020 at 9:15 pm
For the first time, a blood test has been shown to help detect many types of cancer in a study of thousands of people with no history or symptoms of the ...
via Google News and Bing News